http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DK-175969-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7529e5a25424c0fed678ea01a45cef89 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-46 |
filingDate | 2001-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2005-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d75e3335254a15511163058feca94fc2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc2e5afc051f3adbcf5a68af3c37287d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17236d8d9a443cea51e5e1e5bb938070 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb1d8f8e18606908ed9a41c463ef61e5 |
publicationDate | 2005-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | DK-175969-B1 |
titleOfInvention | Process for Purification of Interleukin 1 Inhibitors |
abstract | A pure interleukin-1 inhibitor (IL-1 INH) is claimed characterised by an inhibitory activity to the LAF activity of IL-1, to the MCF activity of IL-1, to IL-1 mediated fibroblast proliferation and non-inhibitory activity to the INF alpha mediated prodn. of PGE2 and collagenase. Also claimed is a recombient DNa molecule comprising a DNA sequence which codes on expression for the IL-1 INH. |
priorityDate | 1987-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 281.